Clinical trial

Effect of Linagliptin on Insulin Sensitivity and Pancreatic Beta Cell Function in Patients With Type 2 Diabetes Mellitus

NCT02097342

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2013-12-01

PhasePHASE4

Study timeline

Study start (unknown)2013-12-01Date precision: month

Registry last updated2014-04-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetes Mellitusunresolved

Insulin Sensitivity/Resistanceunresolved

Interventions

LinagliptinDRUG · verified · RxNorm: linagliptin

PlaceboDRUG

VogliboseDRUG

Sponsors & collaborators

Post Graduate Institute of Medical Education and Research, Chandigarhlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02097342 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.